Renew Medical Clinics

Slide 1
Treatment Centres for Addiction and Dependence
Slide 1
Treatment Centres for Addiction and Dependence
Slide 1
Treatment Centres for Addiction and Dependence
Slide 1
Treatment Centres for Addiction and Dependence
previous arrowprevious arrow
next arrownext arrow

Personalized treatment plans for addiction with methadone, suboxone and morphine

Flexible appointment times including weekends, and easily accessible locations

Knowledgeable and experienced licensed physicians

RAAM model, Rapid Access Addiction Medicine with no wait

Welcome To Renew Medical Clinics

Welcome to Renew Clinics, where we specialize in providing compassionate care for individuals struggling with dependency or addiction to opioids such as oxycontin, fentanyl, dilaudid, or percocet. We also provide primary care for mental health and associated conditions such as ADHD, alcoholism, and testosterone deficiency. At our clinics, we understand the profound impact that these health issues can have on individuals and their families, and we are dedicated to helping our patients navigate their journey toward recovery. With a team of experienced and empathetic healthcare professionals, we offer a range of services tailored to meet the unique needs of each individual. You can trust our clinic to provide expert care in a safe and supportive environment. Your health and wellness matter to us, and we’re here to help you every step of the way. Welcome to a place where healing begins.  

All Services Are Provided by Qualified Physicians and Covered By OHIP

Get Started

We Can Help With a Variety of Medical Conditions Without Need For a Referral.

Services We offer:

Alcoholism

Alcohol Use Disorder Alcohol use disorder is a pattern of alcohol use that involves problems controlling your drinking,

Read More

Suboxone Program

What is Suboxone maintenance treatment program? Suboxone (or by its generic name, buprenorphine) treatment is a widely used

Read More

Learn About Renew Medical Clinics Services:

Methadone maintenance

Methadone maintenance treatment has been used for over 50 years to bring life back to those suffering from addiction to opioids such as heroin, oxycontin, hydromorphone, fentanyl, morphine, opium, etc.

Methadone is a long-term treatment for individuals with opioid use disorder. It involves the regular, supervised administration of methadone, to reduce cravings and withdrawal symptoms associated with opioid dependence.

Unlike short-acting opioids like fentanyl, methadone provides a stable level of medication in the bloodstream, preventing the highs and lows of opioid use and helping patients regain stability in their lives.

Methadone allows individuals to manage their addiction by reducing illicit opioid use, lowering the risk of overdose, and improving overall quality of life. It also enables patients to focus on other aspects of recovery.

Methadone is taken orally, usually once daily, under the supervision of a healthcare provider to ensure compliance and minimize misuse.

The goal of MMT is to stabilize the patient’s condition and, over time, potentially taper off methadone, though many patients may remain on maintenance for an extended period to prevent relapse.

Suboxone maintenance

Suboxone maintenance treatment has been used for several decades to bring life back to those suffering from addiction to opioids such as heroin, oxycontin, hydromorphone, fentanyl, morphine, opium, etc.

Suboxone is generally is a long-term treatment approach for individuals with opioid use disorder. It involves the regular, supervised administration of suboxone to reduce cravings and withdrawal symptoms.

Unlike short-acting opioids like fentanyl, suboxone provides a stable level of medication in the bloodstream, preventing the highs and lows of opioid use and helping patients regain stability in their lives.

Suboxone programs allow individuals to manage their addiction by reducing illicit opioid use, lowering the risk of overdose, and improving overall quality of life.

It also enables patients to focus on other aspects of recovery, such as mental health care, employment, and rebuilding relationships. suboxone is taken, under the supervision of a physician to ensure compliance and minimize misuse.

The goal of the suboxone program is to stabilize the patient’s condition and, over time, potentially taper off suboxone, though many patients may remain on maintenance for an extended period to prevent relapse.

Kadian maintenance

Slow-release oral morphine (SROM) is an option for patients with severe opioid use disorder (OUD).

Morphine is particularly an option when suboxone and methadone have been ineffective, are not appropriate, are not enough, or have been refused.

Clinical recommendations suggest considering slow-release morphine (kadian) for adults with moderate-severe addiction to opioids such as fentanyl in certain circumstances.

Slow-release morphine (kadian) appears to be comparable to methadone as an opioid agonist therapy for patients with opioid addiction.

With morphine, opioid-addicted patients report reduced cravings, few side effects, and elevated mood, as well as some evidence of improved function.

The goal of morphine dosing is to find a dose that manages withdrawal symptoms and cravings without causing sedation or adverse effects.

Alcoholism

Stress or Psychogenic weight gain refers to weight gain driven primarily by psychological factors rather than physical or metabolic causes. This phenomenon often arises from emotional and mental health challenges such as stress, anxiety, depression, and emotional eating.

When individuals experience these psychological states, they may turn to food for comfort, leading to increased caloric intake, especially of high-sugar, high-fat, and high-calorie foods.

Individuals experiencing psychogenic weight gain may engage in frequent episodes of emotional eating, where food consumption becomes a coping mechanism for stress, anxiety, or depression.

Additionally, psychogenic weight gain can be accompanied by feelings of guilt or shame related to eating habits, further perpetuating the cycle of emotional eating and weight gain.

Managing psychogenic weight gain involves a multifaceted approach: psychotherapy, diet change, exercise and medications. Medications that can help treat psychogenic weight gain are often focused on addressing the underlying psychological factors contributing to the weight gain.

Weight loss medications like orlistat or like semaglutide (Ozempic or Wegovy) may be considered in some cases. Medications used to treat Binge Eating Disorder (BED) include lisdexamfetamine (Vyvanse) can also help.

Cocaine addiction

Cocaine addiction is a chronic, relapsing condition characterized by compulsive drug-seeking behavior despite harmful consequences.

Cocaine, a powerful stimulant, increases feel-good chemical levels in the brain, leading to intense feelings of euphoria, energy, and confidence.
Repeated use of cocaine can quickly lead to tolerance, dependence, and addiction. Individuals may experience a range of physical and psychological effects, including cardiovascular issues, anxiety, paranoia, and cognitive impairment.
The addiction cycle is driven by cravings and withdrawal symptoms like fatigue, depression, and irritability.
Treatment typically involves behavioral therapies, counseling, and support groups, as well as treatment of associated psychiatric conditions.

Treatment can include medications such as lisdexamfetamine, guanfacine , wellbutrin, and modafinil.

Methadone to suboxone conversion

Switching from methadone to Suboxone requires careful planning with a healthcare provider to ensure safety and minimize withdrawal symptoms.
The transition from methadone to suboxone usually involves tapering down your methadone dose gradually until you are at a lower dose (often around 30 mg or less).
Once stabilized at lower dose of methadone, your doctor will stop methadone and wait for withdrawal symptoms to begin, which typically occurs 24-48 hours after the last dose.
Starting suboxone too early after stopping methadone can lead to precipitated withdrawal. Your doctor will guide you through the process, including the timing and dosage of Suboxone, and will monitor your response closely during the transition.
Regular follow-up and support are crucial for a successful switch. In the following several days and weeks, you can be stabilized on an effective dose of suboxone, which can then be continued for maintenance.

Switching from subxone to methadone is less cumbersome than the opposite. In most cases, suboxone can be stopped with methadone starting the next day at the usual starting dose of methadone.

Testosterone

Binge Eating Disorder (BED) is characterized by recurrent episodes of consuming large amounts of food in a discrete period, often accompanied by a sense of loss of control and distress.
BED typically begins in late adolescence or early adulthood and can persist for years if untreated.
It is associated with significant physical health concerns such as obesity, diabetes, and cardiovascular disease, as well as psychological issues including depression, anxiety, and low self-esteem.
Lisdexamfetamine (Vyvanse) is the only medication currently currently approved by Health Canada specifically for BED. It is a stimulant that helps regulate impulse control and reduce binge eating episodes.
The excessive caloric intake during binge episodes can lead to significant weight gain. Psychologically, untreated BED is associated with heightened levels of anxiety, depression, and low self-esteem due to feelings of guilt, shame, and loss of control.

Treatment can include medications such as lisdexamfetamine (Vyvanse), and selective serotonin reuptake inhibitors (SSRIs) like fluoxetine (Prozac), sertraline (Zoloft).

Mental health

Binge Eating Disorder (BED) is characterized by recurrent episodes of consuming large amounts of food in a discrete period, often accompanied by a sense of loss of control and distress.
BED typically begins in late adolescence or early adulthood and can persist for years if untreated.
It is associated with significant physical health concerns such as obesity, diabetes, and cardiovascular disease, as well as psychological issues including depression, anxiety, and low self-esteem.
Lisdexamfetamine (Vyvanse) is the only medication currently currently approved by Health Canada specifically for BED. It is a stimulant that helps regulate impulse control and reduce binge eating episodes.
The excessive caloric intake during binge episodes can lead to significant weight gain. Psychologically, untreated BED is associated with heightened levels of anxiety, depression, and low self-esteem due to feelings of guilt, shame, and loss of control.

Treatment can include medications such as lisdexamfetamine (Vyvanse), and selective serotonin reuptake inhibitors (SSRIs) like fluoxetine (Prozac), sertraline (Zoloft).

Learn more about opioid addiction:

Scroll to Top